Da Volterra Endorses Lord Jim O’Neill’s Global Review on AMR and its Recommendations to Defeat Superbugs

Da Volterra Endorses Lord Jim O’Neill’s Global Review on AMR and its Recommendations to Defeat Superbugs


Retour vers la page actualités

Da Volterra Endorses Lord Jim O’Neill’s Global Review on AMR and its Recommendations to Defeat Superbugs

Da Volterra pledges support for the press release today from Jim O’Neill’s global Review on AMR, which ‘will set out its final recommendations, providing a comprehensive action plan for the world to prevent drug-resistant infections and defeat the rising threat of superbugs – something that could kill 10 million people a year by 2050, the equivalent of 1 person every 3 seconds, and more than cancer kills today.’ Da Volterra’s CEO, Florence Séjourné was asked to comment on the report, and offered her support in her statement “(we) are strongly supportive of the vision and pragmatic solutions proposed by the UK Review on AMR.  We, as actors of innovation in the field, face every day the funding needs, path to market and other healthcare payers issues well raised by the Jim O’Neill team, which limit and even sometimes prevent us from translating potential great innovative ideas to products on the market. We are hopeful that worldwide leaders will not only acknowledge conclusions of this report, but actually decide to join forces and act now to win the battle against resistance to antibiotics.”

Read the full report for the action plan.